Media-OutReach Newswire Case Study Highlights INDIBA 448 kHz Radiofrequency’s Role in Visceral Fat Reduction and Prevention of Fat Accumulation
Politics & Law FLC appeal hearing postponed, former group chairman claiming life-threatening health conditions
Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire Chubb Life Hong Kong Launches Serene Care Critical Illness Protector - The Market's Only Pure Critical Illness Basic Plan with Limited Premium Payment Terms